InsiderClue
Insiders · Profile

Steinhart Richard I

Chief Financial Officer at BioXcel Therapeutics · Director at Actinium Pharmaceuticals. Filing since 14 Apr 2016. CIK 0001293789

BTAI BioXcel Therapeutics, Inc. Chief Financial Officer · 12 trades ATNM Actinium Pharmaceuticals, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
BTAI BioXcel Therapeutics, Inc.
20 May 2026
Chief Financial Officer
Sold on a plan
6,845
$7.43K
20.7%
BTAI BioXcel Therapeutics, Inc.
16 Dec 2024
Chief Financial Officer
Sold on a plan
577
$206.98
2.7%
BTAI BioXcel Therapeutics, Inc.
3 Oct 2024
Chief Financial Officer
Sold on a plan
7,175
$3.95K
26.1%
BTAI BioXcel Therapeutics, Inc.
16 Sep 2024
Chief Financial Officer
Sold on a plan
356
$245.60
5.4%
BTAI BioXcel Therapeutics, Inc.
17 Jun 2024
Chief Financial Officer
Sold on a plan
372
$469.54
6.4%
BTAI BioXcel Therapeutics, Inc.
4 Apr 2024
Chief Financial Officer
Sold on a plan
1,069
$2.82K
18.3%
BTAI BioXcel Therapeutics, Inc.
15 May 2023
Chief Financial Officer
Sold on a plan
5,000
$135.86K
76.9%
BTAI BioXcel Therapeutics, Inc.
15 Mar 2023
Chief Financial Officer
Sold, plan not stated
2,084
$40.64K
58.1%
BTAI BioXcel Therapeutics, Inc.
1 Feb 2021
Chief Financial Officer
Sold, plan not stated
3,750
$180.56K
71.4%
BTAI BioXcel Therapeutics, Inc.
3 Dec 2018
Chief Financial Officer
Bought
500
$2.60K
50.0%
BTAI BioXcel Therapeutics, Inc.
30 Nov 2018
Chief Financial Officer
Bought
500
$2.50K
100%
BTAI BioXcel Therapeutics, Inc.
29 Nov 2018
Chief Financial Officer
Bought
500
$2.50K
opened
ATNM Actinium Pharmaceuticals, Inc.
14 Apr 2016
Director
Bought
2,500
$5.03K
opened
13 decisions on file.